Abatacept is used:
Abatacept is in a class of medications called selective costimulation modulators (immunomodulators). It works by blocking the activity of T-cells, a type of immune cell in the body that causes swelling and joint damage in people who have arthritis.
Abatacept comes as a powder to be mixed with sterile water to be given intravenously (into a vein) and as a solution (liquid) in a prefilled syringe or an autoinjector to be given subcutaneously (under the skin). It is usually given by a doctor or nurse in a doctor's office or healthcare facility when given intravenously. It also my be given subcutaneously by a doctor or nurse or you or a caregiver may be told to inject the medication subcutaneously at home.
When abatacept is given intravenously to treat rheumatoid arthritis or psoriatic arthritis, it is usually given every 2 weeks for the first 3 doses and then every 4 weeks for as long as treatment continues.
When abatacept is given intravenously to treat polyarticular juvenile idiopathic arthritis in children 6 years and older, it is usually given every two weeks for the first two doses and then every four weeks for as long as treatment continues.
If you are receiving abatacept intravenously to treat rheumatoid arthritis, psoriatic arthritis, or polyarticular juvenile idiopathic arthritis in children 6 years of age and older, it will take about 30 minutes for you to receive your entire dose.
When abatacept is given subcutaneously to treat rheumatoid arthritis or psoriatic arthritis in adults and children 2 years of age and older and polyarticular juvenile idiopathic arthritis in children 2 years and older, it is usually given once weekly.
When abatacept is given intravenously to prevent graft versus host disease, it is usually injected slowly over 60 minutes on the day before hematopoietic stem-cell transplant and then on days 5, 14, and 28 after the transplant.
If you will be injecting abatacept injection by yourself at home or having a friend or relative inject the medication for you, ask your doctor to show you or the person who will be injecting the medication how to inject it. You and the person who will be injecting the medication should also read the manufacturer's written instructions for use that come with the medication.
Before you open the package containing your medication, check to be sure that the expiration date printed on the package has not passed. After you open the package, look closely at the liquid in the syringe. The liquid should be clear or pale yellow and should not contain large, colored particles. Call your pharmacist, if there are any problems with the package or the syringe. Do not inject the medication.
You may inject abatacept injection anywhere on your stomach or thighs except your navel (belly button) and the area 2 inches around it. If someone else will be injecting the medication for you, that person can also inject it into the outer area of your upper arm. Use a different spot for each injection. Do not inject abatacept injection into a spot that is tender, bruised, red, or hard. Also, do not inject into areas with scars or stretch marks.
Remove the prefilled syringe or prefilled autoinjector from the refrigerator and allow it to warm to room temperature for 30 minutes before using it. Do not warm abatacept injection in hot water, microwave, or place it in sunlight. Do not remove the needle cover while allowing the prefilled syringe to reach room temperature.
Your doctor will give you the manufacturer's patient information sheet to read before you receive each dose of abatacept. Read the information carefully and ask your doctor any questions you have.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
Before using abatacept,
Unless your doctor tells you otherwise, continue your normal diet.
If you are receiving abatacept intravenously and miss an appointment to receive an abatacept infusion, call your doctor as soon as possible.
If you are receiving abatacept subcutaneously and miss a dose, ask your doctor for a new dosing schedule.
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
Abatacept may increase the risk of developing certain types of cancer including lymphoma (cancer that begins in the cells that fight infection) and skin cancer. People who have had severe rheumatoid arthritis for a long time may have a greater than normal risk of developing these cancers even if they do not use abatacept. Your doctor will also check your skin for any changes during your treatment. Talk to your doctor about the risks of using this medication.
Abatacept may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
Keep the prefilled syringes and autoinjectors in the original carton it came in to protect them from light and out of reach of children. Store abatacept prefilled syringes or autoinjectors in the refrigerator and do not freeze.
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to abatacept injection.
Before having any laboratory test, tell your doctor and the laboratory personnel that you are using abatacept injection.
If you are diabetic and receiving abatacept intravenously, abatacept injection may give falsely high blood glucose readings on the day of your infusion. Talk to your doctor or pharmacist about blood glucose monitoring tests to use during your treatment.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.
The American Society of Health-System Pharmacists, Inc. represents that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. makes no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. does not endorse or recommend the use of any drug. The information is not a substitute for medical care.
AHFS® Patient Medication Information™. © Copyright, 2024. The American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by ASHP.